Further interpretation of the data suggests that BPC 157 might modulate focal adhesion kinase and paxillin-associated pathways involved in F-actin formation
Standard Shipping: 25 business days
Order online or walk in at 8201 Broadway, Suite 113
Animal studies -- primarily in rats -- have shown BPC-157 may accelerate healing of tendons, ligaments, muscles, and bones
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication